Leonardo Art/Science Evening Rendezvous of 12 December 2019

Exploring the Frontiers of Knowledge and Imagination, Fostering Interdisciplinary Networking

Stanford, 12 December 2019
LiKaShing building - Room LK130
Chaired by Piero Scaruffi and prof. Curtis Frank

The LASERs are an international program of evening gatherings that bring artists and scientists together for informal presentations and conversation with an audience. See the program for the whole series and the dates for the Bay Area. The event is free and open to everybody. Email me if you want to be added to the mailing list for the LASERs. Like previous evenings, the agenda includes some presentations of art/science projects, news from the audience, and time for casual socializing/networking.
Where: Stanford University, LiKaShing building - Room LK130
There should be ample parking in the structure on corner of Campus Drive West and Roth Way. (Stanford map)
Parking is mostly free at Stanford after 6pm.
Program (the order of the speakers might change):
  • 7:00-7:25: Daniel Dever (Stanford/ Regenerative Medicine) on "Repairing disease genes in hematopoietic stem cells for developing next-generation gene therapies" Hematopoietic stem cell (HSC) transplantation has the power to cure inherited diseases... Read more
  • 7:25-7:50: Jaroslaw Kapuscinski (Intermedia Composer) on "Talking of Intermedia" AI technology aids interactive audiovisuality in Chopin-inspired piano performances... Read more
  • 7:50-8:10: BREAK. Before or after the break, anyone in the audience currently working within the intersections of art and science will have 30 seconds to share their work. Please present your work as a teaser so that those who are interested can seek you out during social time following the event.
  • 8:10-8:35: Danton Char (Stanford/ Anesthesia Dept) on "AI, Ethics & Healthcare: Challenges" The ethical implications of using machine-learning tools in making health care decisions for patients... Read more
  • 8:35-9:00: Liqun Luo (Stanford/ Biology) on "What motivates animals to do what they do?" Neuroscience's new tools to test these psychological theories of motivation... Read more
  • 9:00pm-9:30pm: Discussions, networking You can mingle with the speakers and the audience

Watch it live on your mobile device by using
periscope @lasertalks
twitter @lasertalks
Watch it live on your personal computer by using
See also...
  • Other LASER series
  • Archive of past LASERs
  • Leonardo ISAST
  • Art, Technology, Culture Colloquia
  • ScienceSchmoozer
  • LAST Festival
  • Other recommended events
    • Danton Char is Assistant Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric) at the Stanford University Medical Center. Dr. Char's K01 from NHGRI examines the ethical challenges of implementing whole genome sequencing in the care of critically ill children, particularly those with congenital cardiac disease. His long-term goal is to continue to identify and address ethical concerns associated with the implementation of next generation technologies to bedside clinical care, like whole genome sequencing and its attendant technologies like machine learning.
    • Daniel Dever is a research instructor in Dr. Matthew Porteus' lab at Stanford University in the Department of Pediatrics. While completing his postdoctoral work, Dr. Dever helped develop a CRISPR-Cas9-based gene targeting methodology in CD34+ hematopoietic stem cells. This research led to Dr. Dever and others in the Porteus Lab to successfully target more than 15 genes in primary blood cells that are associated with hematopoietic diseases. Dr. Dever focuses on using CRISPR-Cas9 to study gene targeting mechanisms in human hematopoietic cells. The hope is that this research will lead to the development of novel therapeutics for blood and immune system diseases. Dr. Dever is currently heading an Investigational New Drug (IND)- enabling study for FDA approval for the first human trials to treat severe sickle cell disease using CRISPR-Cas9-based targeting techniques.
    • Jaroslaw Kapuscinski is Associate Professor and Chair of the Department of Music at Stanford University. Trained first as a pianist and composer at the Chopin Academy of Music in Warsaw (1987, 1991), Jaroslaw Kapuscinski developed an intermedia idiom during residencies and studies at Banff Centre for the Arts (1988-89), National Audiovisual Institute (INA) in Paris (1991-92), and doctoral studies at the University of California, San Diego (1992-97). His work was presented among others at New York MOMA; ZKM in Karlsruhe; Centre Pompidou in Paris; and Reina Sofia Museum in Madrid. He received awards at the UNESCO Film sur l'Art festival in Paris (1992), VideoArt Festival Locarno (1992, 1993), and Festival of New Cinema and New Media in Montr‚al (2000). He has taught at McGill University in Montreal (2000-01) and Conservatory of Music at the University of the Pacific (2004-08) and lectured internationally.
    • Liqun Luo is the Ann and Bill Swindells Professor in the School of Humanities and Sciences and Professor, by courtesy, of Neurobiology at Stanford University. He grew up in Shanghai, China, and earned his bachelor's degree from the University of Science & Technology of China. After receiving his PhD at Brandeis University and postdoctoral training at UCSF, Dr. Luo started his own lab at Stanford University in 1996. Together with his postdoctoral fellows and graduate students, Dr. Luo studies the development and function of neural circuits in fruit flies and mice. He is also an Investigator of the Howard Hughes Medical Institute. He teaches neurobiology to undergraduate and graduate students. His single-author textbook "Principles of Neurobiology" (Garland Science 2015) is widely used for undergraduate and graduate courses across the world. Dr. Luo is a recipient of several awards and a member of the National Academy of Sciences and a Fellow of the American Academy of Arts and Sciences.
    • Piero Scaruffi is a cultural historian who has lectured in three continents and published several books on Artificial Intelligence and Cognitive Science, the latest one being "The Nature of Consciousness" (2006). He pioneered Internet applications in the early 1980s and the use of the World-Wide Web for cultural purposes in the mid 1990s. His poetry has been awarded several national prizes in Italy and the USA. His latest book of poems and meditations is "Synthesis" (2009). As a music historian, he has published ten books, the latest ones being "A History of Rock and Dance Music" (2009) and "A History of Jazz Music" (2007). His latest book of history is "A History of Silicon Valley" (2011). The first volume of his free ebook "A Visual History of the Visual Arts" appeared in 2012. His latest book is "Intelligence is not Artificial" (2013). He has also written extensively about cinema and literature. He founded the Leonardo Art Science Evening Rendezvous (LASER) in 2008. Since 2015 he has been commuting between California and China, where several of his books have been translated.

    Extended abstracts:

    In the world of art today, interweaving words, images and sounds, is ubiquitous. Dynamically developing digital technologies transform how it is done and conceptualized. What are some of the new affordances and what is their impact? The presentation will engage with these questions from the perspective of a composer, performer and scholar of intermedia. Examples discussed will include Chopin-inspired piano performances in which AI technology aids interactive audiovisuality and hyperlinked online studies of Japanese Noh Theater.

    I will discuss psychological theories of motivation dates back in the early 20th century. Modern neuroscience has produced new tools to critically test these theories and provide new insights into the neural basis of motivation.

    The ethical implications of using machine-learning tools in making health care decisions for patients.

    Hematopoietic stem cell (HSC) transplantation has the power to cure inherited diseases of the blood and immune system. The CRISPR-Cas9 system now enables targeted manipulations of the HSC genome that has revolutionized the concept of correcting disease-causing genetic mutations in patient-derived autologous HSCs. I will summarize the preclinical data for our lead therapeutic program that is focusing on gene correction of the Sickle Cell Disease-causing E6V point mutation in autologous HSCs, which is primed to enter a clinical trial in 2020 at Stanford.

    Photos and videos of this evening


    The Stanford LASERs are sponsored by the Stanford Deans of: Engineering; Humanities & Sciences; Research; and Medicine; by Continuing Studies.